| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |